In the rapidly evolving field of oncology, Antibody-Drug Conjugates (ADCs) are emerging as a revolutionary approach to targeted cancer therapy. With the increasing demand for precision medicine, ADC discovery services  are becoming crucial in developing effective treatments. These services focus on evaluating ADCs through innovative Bystander Effect Assays, which play a pivotal role in understanding how cytotoxic payloads affect both target antigen-positive and neighboring antigen-negative cancer cells. By leveraging advanced cell culture techniques and real-time imaging, ICE Bioscience offers comprehensive ADC testing services that provide deep insights into payload diffusion and impact, ultimately enhancing therapeutic efficacy.   Table of contents: The Role of In Vitro Bystander Effect Assays in Targeted Cancer Therapy Exploring the Mechanisms of Bystander Effect ADC Assays How ADC Bystander Effect Assays Enhance Tumor Treatment Strategies The Future of Cancer Researc...